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among groups were estimated by χ2 test, bone metastasis-free survival 
was analyzed by Kaplan-Meier method. The prognostic impact of 
clinicopathologic parameters and biomarker expression was evaluated 
by Cox propotional hazards model.
Results: BSP expression was associated with BM(P=0.027), OPN 
expression could not reach statistical signiﬁcance(P=0.495). Survival 
analysis demonstrated that strong expression of BSP(P=0.036), N 
stage(P=0.000) and overall stage(P=0.001) were associated with time 
interval to BM. Multivariate analysis showed BSP expression(RR=1.7
79,P=0.012) and overall stage(RR=1.620,P=0.005) were independent 
prognostic factors for BM. 
Conclusions: BSP protein expression in the primary resected NSCLC 
is strongly associated with BM and could be used to identify high-risk 
patients, and further improve treatment of NSCLC. Correlation of OPN 
protein expression and bone metastasis need further investigation.
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Background: Lung cancer remains to be the leading cause of mortal-
ity for cancer deaths despite the availability of various chemo- and 
radiotherapeutic regimens. One of the limitations is due to resistance 
of cancers cells to apoptotic stimuli of various anti-neoplastic agents. 
Autophagic cell death has recently been shown to be increased in the 
irradiated apoptosis-incompetent cells.
Method: We tested whether inhibition of apoptosis and induction of 
autophagy can be utilized as an adjunctive to the radiation therapy, 
using cell culture and xenograft models of lung cancer. In order to test 
this hypothesis, we asked whether inhibitor of Caspase-3, Z-DEVD, 
and inducer of autophagy, RAD001, can enhance the cytotoxic effects 
of irradiation in human lung cancer cells, H460. 
Result: We found that combination of Z-DVED and RAD001 
markedly enhanced radiosensitization of H460 cells than individual 
treatment alone both in vitro as well as xenograft murine model. The 
enhanced radiosensitization was associated with upregulation of au-
tophagosome formatiom. Furthermore, when we addressed the speciﬁc 
cellular behavior associated with combination treatment, we observed 
defects in angiogenesis, inhibition of proliferation, as well as reduction 
in apoptosis. 
Conclusion: We demonstrate that radiation therapy, combined with 
inhibition of Caspase-3 and induction of autophagy, may be a novel 
therapeutic option for lung cancer patients. 
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The aim of this work was to study cytogenetic damages in vivo induced 
by single therapeutic irradiation in population of peripheral blood 
lymphocytes (PBL) of squamous cell lung cancer (SCLC) patients and 
to estimate the possibilities of using these date for prediction of tumour 
radiosensitivity. It becomes especially urgent in connection with accel-
eration of growth in the number of oncological cases in areas suffering 
from the Chernobyl accident. 
The estimation of lymphocytes with micronuclei and apoptosis in PBL 
of the patients was carried out before and after single therapeutic irra-
diation (4 Gy). The criterion of patient somatic cell radiosensitivity was 
the response of tumour tissue to radiotherapy. Depending on treatment 
result all patients were divided into radiosensitive and radioresistant 
groups. 
It was revealed that the levels of spontaneous mutational (0,32±0,10%) 
and cell-lethal (6,33±0,45%) processes in PBL in vivo in SCLC pa-
tients with clinically radiosensitive tumours were 1,5-2 fold as high as 
in the control (0,14±0,08% - cells with micronuclei; 4,13±0.67% - cells 
with apoptosis), and in patients with clinically radioresistant tumours 
didn’t differ from those in people without oncopathology. 
After single therapeutic irradiation signiﬁcant increase (1,5-2 fold) 
in the lymphocyte level with micronuclei and degenerative disorders 
was observed in patients with high tumour tissue radiosensitivity in 
comparison with the spontaneous level in the same patients, with the 
absence of essential changes being noted between the levels in patients 
with radioresistant tumour tissue. 
Thus, studying cytogenetic parameters of the mutational process and 
the cell-lethal effect in vivo in PBL of patients suffering from SCLC 
has established additional criteria for estimating and predicting radio-
sensitivity of somatic cells in SCLC patients for increasing radiothera-
phy efﬁciency.
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Background: Non-small cell lung cancer (NSCLC) cells are com-
monly progressed to radiation-resistant state, making it difﬁcult to treat 
by conventional radiotherapy. The aim of this study is to establish the 
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radiation-resistant cell line, and to investigate the mechanism underly-
ing the radioresistancy in non small cell lung cancer cells.
Methods: A human NSCLC cell line, H460, was irradiated with x-rays 
to an accumulated dose of 40 Gy over 10 weeks to produce the radia-
tion-resistant cell line. To characterize the radiation-resistant cells, we 
checked the morphological features, clonogenicity, radiosensitivity, cell 
growth kinetics, and the levels for several candidate proteins.
Results: We established the radiation-resistant cell line and named as 
H460R. Clonogenic assay and MTT assay clearly showed that H460R 
cells were radioresistance as compared with mother H460 cells. FACS 
analysis revealed that x-ray did not induce the apoptosis in H460R 
cells, while many of H460 cells died. Consistent with, x-ray induced 
the cleavage of PARP, an indicator for apoptotic cell death, in H460 
cells, but not in H460R cells. To ﬁnd the putative upstream regulators 
for radiation-induced apoptosis, we focused on the PKC superfamily 
proteins, and found that x-ray markedly induced PKCδ activation in 
radio-sensitive H460 cells, but not in radio-resistant H460R cells. 
Conclusions: These results indicate that radioresistance of NSCLC cell 
is possibly mediated by a mechanism dependent on PKCδ, suggesting 
that the combined therapy of x-ray and PKCδ activators may improve 
the efﬁcacy of cancer treatment. 
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Background: Future radiotherapy for cancer treatment will likely al-
low the use of different radiation qualities including high LET acceler-
ated ions. In order to select for tumours which efﬁciently can be treated 
with high LET radiotherapy, there is a need to characterize which 
signalling pathways that is of importance for accelerated ion therapy. In 
the present study we compared apoptotic signalling in response to low 
and high LET radiation in NSCLC cells. 
Methods: NSCLC cells have been irradiated with either high LET 
accelerated nitrogen or low LET photons and apoptotic signalling 
parameters (caspase-3 activation, mitochondrial depolarization, Bcl-2 
family protein activation, Mitogen activated protein kinase (MAPK) 
activation) have been examined at various times post irradiation using 
a combination of ﬂow cytometry, western blotting and immunoﬂures-
cence microscopy analysis. 
Results and Conclusion: We found that high LET radiation can trig-
ger apoptotic signalling in low LET radiation resistant NSCLC cells. 
Importantly, we show for the ﬁrst time that apoptotic signalling in re-
sponse to accelerated nitrogen ions includes activation of Bak and Bax, 
depolarization of mitochondria and release of cytochrome c, activa-
tion of caspase-3/7 and induction of apoptotic morphology. Moreover, 
our data suggest that signalling by the MAPK JNK is of importance 
for apoptotic propensity after exposure to accelerated nitrogen ions. 
Importantly, as the NSCLC cells used in the present study neither show 
Bak/Bax nor JNK activation after exposure to low LET γIR but do so 
after irradiation with high LET accelerated nitrogen ions, our results 
suggest that low and high LET radiation utilizes different signalling 
pathways from the DNA damage to Bak/Bax and JNK activation. 
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We have found that human lung cancer tumors and experimental mouse 
tumors develop unique angiogenic phenotypes characterized by pre-
dominant expression of one family of angiogenic factors over another. 
Our previous data suggest that in lung cancer, angiogenic CXC chemo-
kines account for a signiﬁcant degree of the variability in angiogenesis 
between tumors (as measured by vessel density staining). On the other 
hand, while VEGF expression was not associated strongly with the vas-
cularity of the tumor, it remained a poor prognostic factor. Mizukami 
et al recently showed that in cells unable to express VEGF in response 
to hypoxia, K-ras mutations favored the expression of the angiogenic 
CXC chemokine CXCL8, through NADPH-oxidase (NOX) mediated 
generation of H2O2 and activation of NFκB. This is highly relevant to 
our study of human and mouse lung tumors, in which K-ras mutations 
are quite common. In this study we examined the expression of angio-
genic CXC chemokines by cell lines with mutant or wild type K-ras. 
Mutant K-ras cell lines expressed higher levels of angiogenic CXC 
chemokines compared with wild type K-ras cell lines. This increase in 
CXC chemokine expression was inhibited by pharmacologic inhibitors 
of NADPH-oxidase (NOX) enzymes in K-ras mutant, but not wild type 
cell lines. We also screened 90 human NSCLC tumor specimens for the 
presence of mutations in codon 12 of K-ras. In 23 tumors with mutant 
K-ras, the levels of angiogenic CXC chemokines (103±52 ng/mg) was 
signiﬁcantly higher than in 67 tumors with wild type codon 12 (24±6 
ng/mg. p=0.014). In contrast, the levels of VEGF were not statisti-
cally signiﬁcantly different, but mutant K-ras was associated with at 
trend toward lower levels of (28±7 ng/mg in wild type vs 12±3 ng/.
mg in mutant tumors. p=0.06). Our data suggest a connection between 
a common mutation in lung cancer, and the induction of NOX-depen-
dent H2O2 expression, which in turn promotes the expression of the 
angiogenic CXC chemokines. This is one of several potential pathways 
by which CXC chemokines can be over expressed in lung cancer. Addi-
tionally, our data point out the importance of recognizing the diversity 
of angiogenic phenotypes in cancer, which must be accounted for in 
designing targeted anti-angiogenic therapy. 
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Background: In lung adenocarcinomas, the Ras signaling pathway 
is often constitutively activated, and K-Ras activating mutations are 
widespread. Given the failure in clinical trials of compounds that target 
